CEO of Stryker resigns


On 8 February, The board of directors of Stryker announced that Stephen P MacMillan has resigned as chairman, president and CEO for family reasons, effective immediately. Curt Hartman, vice president and chief financial officer, has been named interim chief executive officer and William U Parfet, lead independent director, becomes non-executive chairman. The board has begun a search for a permanent successor to MacMillan and will consider both internal and external candidates.

“The board is thankful for Steve’s leadership over the past nine years as the company has continued to grow in the midst of a difficult economic period,” said Parfet. “We understand and support his decision to step down for family reasons and wish him well in his future endeavors.”

MacMillan said, “It has been an enormous privilege to have led Stryker during this period of important change and growth. As I look ahead to the next chapter in my life, I remain confident that the team will continue to execute Stryker’s strategy with distinction and that the company will enjoy continued success in the future.”

Curt Hartman began his career with Stryker in 1990 and has progressed through a variety of leadership positions over the last 22 years, including six years as global president of Stryker Instruments. In April 2009, he was named vice president and chief financial officer. Hartman holds a BS in Aerospace Engineering from the University of Michigan and completed the Advanced Management Program at Harvard Business School.

William Parfet has been a director of Stryker for almost 20 years. He is currently the chairman and CEO of MPI Research, a drug safety and pharmaceutical development company, and has served in that role since 1999. He is a director of Monsanto company, a provider of agricultural products that improve farm productivity, and Taubman Centers, a real estate development company.